BETHESDA, Md.–(EMWNews)–Healthnostics, Inc. (PINK SHEETS: HNSO), a medical and biotechnology

analytics company, is pleased to provide the following update report

regarding the Company’s development and

progress.

Trading in Healthnostics Stock

The recent decrease in our stock price over the past months has occurred

even though the value of our company has increased as described in

recent news releases by Healthnostics. Our opinion is the Company’s

stock is undervalued based upon our assets and the performance of our

recent acquisition, GMD, Inc. Currently there are 1,956,538,155 shares

outstanding, of which approximately 1,200,000,000 shares were issued in

conjunction with the GMD transaction. The float is currently

approximately 440,000,000 shares. Long-term insiders hold over

250,000,000 shares in the float.

The current market selling of our stock has not been undertaken by the

Company nor the insiders.

Strategy

The Company’s strategy is to leverage, build

or acquire compatible healthcare technologies that will create valuable

business offerings from us in the healthcare and biotechnology

information technology market. To that end Healthnostics acquired a

major interest in GMD, Inc. a nationwide durable medical equipment

provider specializing in direct to consumer diabetic supplies. The

company continues to evaluate new acquisition and investment

opportunities that are compatible with our strategy.

GMD, Inc.

GMD’s fiscal year ended June 30, 2008.

Previously the Company announced that GMD was on target for record

revenues of nearly $10 million on a profitable basis. The actual results

will be announced after completion of the year-end closing.

MedBioWeb Corp.

MedBioWeb’s medical and biotechnology

professional portal MedBioWorld.com continues to draw praise from its

users and has an increasing user base. New advertising and partner

affiliate programs are underway that have increased revenue.

Healthnostics is in the process of restructuring the MedBioWeb Corp.

spin-off and preparing a new registration statement. Previously,

Healthnostics announced that the Company had filed a registration

statement to spin-off MedBioWeb Corp., into a new, fully reporting

company.

Clinical Software Systems

MedGuardian, which addresses critical quality improvement issues facing

hospitals today, continues to be successfully marketed to hospital

associations, government and private sector hospitals generating new and

viable future sales opportunities. Healthnostics’

target market for MedGuardian is the 4,200 small to medium sized acute

care hospitals that constitute the majority of hospitals in the U.S.

For further information please visit Healthnostics www.healthnostics.com,

MedBioWorld www.medbioworld.com,

MedNets www.mednets.com, and

FamilyMedicalNet www.familymedicalnet.com.

This press release may contain certain statements that are not

descriptions of historical information, but are forward-looking

statements within the meaning of Section 27A of the Securities Act of

1933 and Section 21E of the Exchange Act of 1934. These forward-looking

statements refer to matters that involve risks and uncertainties. Such

statements reflect management’s current views and are based on certain

assumptions. Actual results could differ materially from the assumptions

currently anticipated.

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions